GREGORY POKRYWKA: Open Payments
NPI 1417082322 · KENSINGTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,994 in 67 payments from 16 companies in 2025. Trend: 2023 $34,704 · 2024 $28,047 · 2025 $9,994
Speaker / faculty: $5,900Consulting: $2,250Food & beverage: $1,421Honoraria: $300Travel & lodging: $123
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $3,675 |
| Medicure Pharma Inc. | 1 | $2,500 |
| ARGENX US, INC. | 1 | $2,250 |
| Novartis Pharmaceuticals Corporation | 21 | $347 |
| Chiesi USA, Inc. | 1 | $300 |
| Madrigal Pharmaceuticals | 4 | $259 |
| Novo Nordisk Inc | 6 | $123 |
| Lilly USA, LLC | 7 | $116 |
| Regeneron Pharmaceuticals, Inc. | 3 | $111 |
| Orexo US, Inc. | 5 | $84 |
Products named: REPATHA, Zypitamag, VYVGART HYTRULO, LEQVIO, JUXTAPID, REZDIFFRA, EVKEEZA, Zubsolv.
Industry payments across MD — which companies pay providers there.
